[1]
“Effectiveness of Short-Term Use Denosumab and Risedronate Using β-Crosslaps and Histopathology as a Parameter in Osteoporotic Rat Model”, MKB, vol. 56, no. 3, pp. 197–202, Sep. 2024, doi: 10.15395/mkb.v56.3016.